Index
1 Polyvalent Streptococcus Pneumococcal Vaccines Market Overview
1.1 Product Overview and Scope of Polyvalent Streptococcus Pneumococcal Vaccines
1.2 Polyvalent Streptococcus Pneumococcal Vaccines Segment by Type
1.2.1 Global Polyvalent Streptococcus Pneumococcal Vaccines Market Value Comparison by Type (2023-2029)
1.2.2 9-Valent
1.2.3 13-Valent
1.2.4 23-Valent
1.2.5 Others
1.3 Polyvalent Streptococcus Pneumococcal Vaccines Segment by Application
1.3.1 Global Polyvalent Streptococcus Pneumococcal Vaccines Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Community Clinics
1.3.4 Public Health Agencies
1.3.5 Others
1.4 Global Polyvalent Streptococcus Pneumococcal Vaccines Market Size Estimates and Forecasts
1.4.1 Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue 2018-2029
1.4.2 Global Polyvalent Streptococcus Pneumococcal Vaccines Sales 2018-2029
1.4.3 Global Polyvalent Streptococcus Pneumococcal Vaccines Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Polyvalent Streptococcus Pneumococcal Vaccines Market Competition by Manufacturers
2.1 Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Manufacturers (2018-2023)
2.2 Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Polyvalent Streptococcus Pneumococcal Vaccines Average Price by Manufacturers (2018-2023)
2.4 Global Polyvalent Streptococcus Pneumococcal Vaccines Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Polyvalent Streptococcus Pneumococcal Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Polyvalent Streptococcus Pneumococcal Vaccines, Product Type & Application
2.7 Polyvalent Streptococcus Pneumococcal Vaccines Market Competitive Situation and Trends
2.7.1 Polyvalent Streptococcus Pneumococcal Vaccines Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Polyvalent Streptococcus Pneumococcal Vaccines Players Market Share by Revenue
2.7.3 Global Polyvalent Streptococcus Pneumococcal Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Polyvalent Streptococcus Pneumococcal Vaccines Retrospective Market Scenario by Region
3.1 Global Polyvalent Streptococcus Pneumococcal Vaccines Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Polyvalent Streptococcus Pneumococcal Vaccines Global Polyvalent Streptococcus Pneumococcal Vaccines Sales by Region: 2018-2029
3.2.1 Global Polyvalent Streptococcus Pneumococcal Vaccines Sales by Region: 2018-2023
3.2.2 Global Polyvalent Streptococcus Pneumococcal Vaccines Sales by Region: 2024-2029
3.3 Global Polyvalent Streptococcus Pneumococcal Vaccines Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Region: 2018-2029
3.3.1 Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Region: 2018-2023
3.3.2 Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Region: 2024-2029
3.4 North America Polyvalent Streptococcus Pneumococcal Vaccines Market Facts & Figures by Country
3.4.1 North America Polyvalent Streptococcus Pneumococcal Vaccines Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Polyvalent Streptococcus Pneumococcal Vaccines Sales by Country (2018-2029)
3.4.3 North America Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Polyvalent Streptococcus Pneumococcal Vaccines Market Facts & Figures by Country
3.5.1 Europe Polyvalent Streptococcus Pneumococcal Vaccines Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Polyvalent Streptococcus Pneumococcal Vaccines Sales by Country (2018-2029)
3.5.3 Europe Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Polyvalent Streptococcus Pneumococcal Vaccines Market Facts & Figures by Country
3.6.1 Asia Pacific Polyvalent Streptococcus Pneumococcal Vaccines Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Polyvalent Streptococcus Pneumococcal Vaccines Sales by Country (2018-2029)
3.6.3 Asia Pacific Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Polyvalent Streptococcus Pneumococcal Vaccines Market Facts & Figures by Country
3.7.1 Latin America Polyvalent Streptococcus Pneumococcal Vaccines Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Polyvalent Streptococcus Pneumococcal Vaccines Sales by Country (2018-2029)
3.7.3 Latin America Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Polyvalent Streptococcus Pneumococcal Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Polyvalent Streptococcus Pneumococcal Vaccines Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Polyvalent Streptococcus Pneumococcal Vaccines Sales by Country (2018-2029)
3.8.3 Middle East and Africa Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Polyvalent Streptococcus Pneumococcal Vaccines Sales by Type (2018-2029)
4.1.1 Global Polyvalent Streptococcus Pneumococcal Vaccines Sales by Type (2018-2023)
4.1.2 Global Polyvalent Streptococcus Pneumococcal Vaccines Sales by Type (2024-2029)
4.1.3 Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Type (2018-2029)
4.2 Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Type (2018-2029)
4.2.1 Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Type (2018-2023)
4.2.2 Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Type (2024-2029)
4.2.3 Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share by Type (2018-2029)
4.3 Global Polyvalent Streptococcus Pneumococcal Vaccines Price by Type (2018-2029)
5 Segment by Application
5.1 Global Polyvalent Streptococcus Pneumococcal Vaccines Sales by Application (2018-2029)
5.1.1 Global Polyvalent Streptococcus Pneumococcal Vaccines Sales by Application (2018-2023)
5.1.2 Global Polyvalent Streptococcus Pneumococcal Vaccines Sales by Application (2024-2029)
5.1.3 Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Application (2018-2029)
5.2 Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Application (2018-2029)
5.2.1 Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Application (2018-2023)
5.2.2 Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Application (2024-2029)
5.2.3 Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share by Application (2018-2029)
5.3 Global Polyvalent Streptococcus Pneumococcal Vaccines Price by Application (2018-2029)
6 Key Companies Profiled
6.1 GlaxoSmithKline
6.1.1 GlaxoSmithKline Corporation Information
6.1.2 GlaxoSmithKline Description and Business Overview
6.1.3 GlaxoSmithKline Polyvalent Streptococcus Pneumococcal Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.1.4 GlaxoSmithKline Polyvalent Streptococcus Pneumococcal Vaccines Product Portfolio
6.1.5 GlaxoSmithKline Recent Developments/Updates
6.2 Merck
6.2.1 Merck Corporation Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck Polyvalent Streptococcus Pneumococcal Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Merck Polyvalent Streptococcus Pneumococcal Vaccines Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 Panacea Biotec
6.3.1 Panacea Biotec Corporation Information
6.3.2 Panacea Biotec Description and Business Overview
6.3.3 Panacea Biotec Polyvalent Streptococcus Pneumococcal Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Panacea Biotec Polyvalent Streptococcus Pneumococcal Vaccines Product Portfolio
6.3.5 Panacea Biotec Recent Developments/Updates
6.4 Pfizer
6.4.1 Pfizer Corporation Information
6.4.2 Pfizer Description and Business Overview
6.4.3 Pfizer Polyvalent Streptococcus Pneumococcal Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Pfizer Polyvalent Streptococcus Pneumococcal Vaccines Product Portfolio
6.4.5 Pfizer Recent Developments/Updates
6.5 Pnuvax Incorporated
6.5.1 Pnuvax Incorporated Corporation Information
6.5.2 Pnuvax Incorporated Description and Business Overview
6.5.3 Pnuvax Incorporated Polyvalent Streptococcus Pneumococcal Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Pnuvax Incorporated Polyvalent Streptococcus Pneumococcal Vaccines Product Portfolio
6.5.5 Pnuvax Incorporated Recent Developments/Updates
6.6 Serum Institute
6.6.1 Serum Institute Corporation Information
6.6.2 Serum Institute Description and Business Overview
6.6.3 Serum Institute Polyvalent Streptococcus Pneumococcal Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Serum Institute Polyvalent Streptococcus Pneumococcal Vaccines Product Portfolio
6.6.5 Serum Institute Recent Developments/Updates
6.7 Shinogi
6.6.1 Shinogi Corporation Information
6.6.2 Shinogi Description and Business Overview
6.6.3 Shinogi Polyvalent Streptococcus Pneumococcal Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Shinogi Polyvalent Streptococcus Pneumococcal Vaccines Product Portfolio
6.7.5 Shinogi Recent Developments/Updates
6.8 Shenzhen Kangtai Biological Products
6.8.1 Shenzhen Kangtai Biological Products Corporation Information
6.8.2 Shenzhen Kangtai Biological Products Description and Business Overview
6.8.3 Shenzhen Kangtai Biological Products Polyvalent Streptococcus Pneumococcal Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Shenzhen Kangtai Biological Products Polyvalent Streptococcus Pneumococcal Vaccines Product Portfolio
6.8.5 Shenzhen Kangtai Biological Products Recent Developments/Updates
6.9 SK Bioscience
6.9.1 SK Bioscience Corporation Information
6.9.2 SK Bioscience Description and Business Overview
6.9.3 SK Bioscience Polyvalent Streptococcus Pneumococcal Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.9.4 SK Bioscience Polyvalent Streptococcus Pneumococcal Vaccines Product Portfolio
6.9.5 SK Bioscience Recent Developments/Updates
6.10 Walvax Biotechnology
6.10.1 Walvax Biotechnology Corporation Information
6.10.2 Walvax Biotechnology Description and Business Overview
6.10.3 Walvax Biotechnology Polyvalent Streptococcus Pneumococcal Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Walvax Biotechnology Polyvalent Streptococcus Pneumococcal Vaccines Product Portfolio
6.10.5 Walvax Biotechnology Recent Developments/Updates
6.11 Eli Lilly
6.11.1 Eli Lilly Corporation Information
6.11.2 Eli Lilly Polyvalent Streptococcus Pneumococcal Vaccines Description and Business Overview
6.11.3 Eli Lilly Polyvalent Streptococcus Pneumococcal Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Eli Lilly Polyvalent Streptococcus Pneumococcal Vaccines Product Portfolio
6.11.5 Eli Lilly Recent Developments/Updates
6.12 Abera
6.12.1 Abera Corporation Information
6.12.2 Abera Polyvalent Streptococcus Pneumococcal Vaccines Description and Business Overview
6.12.3 Abera Polyvalent Streptococcus Pneumococcal Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Abera Polyvalent Streptococcus Pneumococcal Vaccines Product Portfolio
6.12.5 Abera Recent Developments/Updates
6.13 Sanofi
6.13.1 Sanofi Corporation Information
6.13.2 Sanofi Polyvalent Streptococcus Pneumococcal Vaccines Description and Business Overview
6.13.3 Sanofi Polyvalent Streptococcus Pneumococcal Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Sanofi Polyvalent Streptococcus Pneumococcal Vaccines Product Portfolio
6.13.5 Sanofi Recent Developments/Updates
6.14 Genentech
6.14.1 Genentech Corporation Information
6.14.2 Genentech Polyvalent Streptococcus Pneumococcal Vaccines Description and Business Overview
6.14.3 Genentech Polyvalent Streptococcus Pneumococcal Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Genentech Polyvalent Streptococcus Pneumococcal Vaccines Product Portfolio
6.14.5 Genentech Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Polyvalent Streptococcus Pneumococcal Vaccines Industry Chain Analysis
7.2 Polyvalent Streptococcus Pneumococcal Vaccines Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Polyvalent Streptococcus Pneumococcal Vaccines Production Mode & Process
7.4 Polyvalent Streptococcus Pneumococcal Vaccines Sales and Marketing
7.4.1 Polyvalent Streptococcus Pneumococcal Vaccines Sales Channels
7.4.2 Polyvalent Streptococcus Pneumococcal Vaccines Distributors
7.5 Polyvalent Streptococcus Pneumococcal Vaccines Customers
8 Polyvalent Streptococcus Pneumococcal Vaccines Market Dynamics
8.1 Polyvalent Streptococcus Pneumococcal Vaccines Industry Trends
8.2 Polyvalent Streptococcus Pneumococcal Vaccines Market Drivers
8.3 Polyvalent Streptococcus Pneumococcal Vaccines Market Challenges
8.4 Polyvalent Streptococcus Pneumococcal Vaccines Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer